- Home
- ALZN vs FAMI Comparison
ALZN vs FAMI Comparison
Compare ALZN & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- FAMI
- Stock Information
- Founded
- ALZN 2016
- FAMI 2015
- Country
- ALZN United States
- FAMI China
- Employees
- ALZN N/A
- FAMI N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- FAMI Packaged Foods
- Sector
- ALZN Health Care
- FAMI Consumer Staples
- Exchange
- ALZN Nasdaq
- FAMI Nasdaq
- Market Cap
- ALZN 2.3M
- FAMI 2.2M
- IPO Year
- ALZN 2021
- FAMI 2018
- Fundamental
- Price
- ALZN $3.20
- FAMI $1.93
- Analyst Decision
- ALZN Strong Buy
- FAMI
- Analyst Count
- ALZN 1
- FAMI 0
- Target Price
- ALZN $180.00
- FAMI N/A
- AVG Volume (30 Days)
- ALZN 429.8K
- FAMI 23.2K
- Earning Date
- ALZN 09-10-2025
- FAMI 08-08-2025
- Dividend Yield
- ALZN N/A
- FAMI N/A
- EPS Growth
- ALZN N/A
- FAMI N/A
- EPS
- ALZN N/A
- FAMI N/A
- Revenue
- ALZN N/A
- FAMI $64,131,332.00
- Revenue This Year
- ALZN $322.64
- FAMI N/A
- Revenue Next Year
- ALZN N/A
- FAMI N/A
- P/E Ratio
- ALZN N/A
- FAMI N/A
- Revenue Growth
- ALZN N/A
- FAMI N/A
- 52 Week Low
- ALZN $2.75
- FAMI $1.43
- 52 Week High
- ALZN $135.54
- FAMI $7.44
- Technical
- Relative Strength Index (RSI)
- ALZN 47.56
- FAMI 51.30
- Support Level
- ALZN $2.81
- FAMI $1.77
- Resistance Level
- ALZN $3.05
- FAMI $1.94
- Average True Range (ATR)
- ALZN 0.17
- FAMI 0.12
- MACD
- ALZN 0.09
- FAMI 0.00
- Stochastic Oscillator
- ALZN 75.01
- FAMI 54.29
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.